SYMPHOGEN
Summary
Symphogen is a privately-owned biotech company focused on oncology and immuno-oncology.
Deals Overview
Total Deals1
Valued Deals0
Total Value-
Avg. Deal Size-
All rights reserved. Copyright © 2025 Datasite
Summary
Symphogen is a privately-owned biotech company focused on oncology and immuno-oncology.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
Senior Management
Martin Olin
CEO
Bernhard Ehmer
Chairman